The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless goods represents a significant regulatory challenge for that FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is thought to act as a sedative at high dosages6. The statements produced by Nicotine River, ECBlend, and various distributors th